Skip to content

The research on blood-activating and stasis-dissolving treatment of intracerebral hemorrhage

The research on two standard traditional Chinese medicine treatment of brain stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002694
Enrollment
Unknown
Registered
2012-11-13
Start date
2010-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intracerebral hemorrhage

Interventions

Group A:Basic therapy + Taking the Chinese decoction oral

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Comply with diagnostic standard of ICH; 2. Patients who present within ischemic stroke whithin 24 hours; 3. Aged 35 to 75 years old; 4. The score of NIHSS scale is 5-22; 5. The score of reformed Rankin scale evaluated before the episode is 0-1; 6. The patients should join in the research voluntarily and should have signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. The cerebral hemorrhage caused by cerebral tumor, cerebral trauma, blood disorder etc; 2. Patients who have osteoarthropathy, psychosis and serious disease of the liver, kidney, hemotopoietic system, endrocrine system etc.; 3. Patients who have active ulcer and blood disorder; 4. Current participation in another experimental treatment; 5. Allergic constitution and known allergy to our medicine ingredients; 6. The dying patients.

Design outcomes

Primary

MeasureTime frame
Modified Rankin scale Score of stroke day 90;

Secondary

MeasureTime frame
the absorptivity of edema and the incidence rate;the cranial CT results taken 24 hour and 72 hour assessment;the survival rate and the disability rate in 3 months;the score of TCM symptom measuring scales;

Countries

China

Contacts

Public ContactZhang Genming
13522973039@163.com+86 13522973039

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026